NIH study proves effectiveness of facial recognition medication adherence tool

The National Institutes of Health (NIH) published a new study that proves the effectiveness of AiCure‘s medication adherence solution, which uses a form of artificial intelligence (AI) for facial recognition to confirm that patients have taken the correct medication, according to a report by Med City News. The findings, which were published in the medical journal Stroke, were based on a 12-week randomized controlled trial that measured the tool’s effect on adherence rates for diabigatran, rivaroxaban, and apixaban and warfarin

Biometrics and banking, fingerprint authentication, wearables and security applications most popular this week

Here is a recap of the most popular biometrics industry news that appeared on BiometricUpdate.com this past week. Fingerprints Morpho has been selected by Australia’s Victoria Police to update biometric capture devices already in use and to increase the number of one-stop livescan fingerprint, palmprint and face capturing stations at up to 92 police stations across metropolitan and remote locations. The kiosks provide significant efficiency gains by allowing police to quickly and accurately collect and verify identity information. Qualcomm CEO

AiCure wins venture capital funding for medication adherence platform

AiCure recently closed a Series A fundraising round of US$12.25 million from a venture capital consortium led by New Leaf Venture Partners, with additional participation from Pritzker Group Venture Capital, Tribeca Venture Partners, and Biomatics Capital, established by Boris Nikolic, former Chief Advisor for Science and Technology to Bill Gates. AiCure is an artificial intelligence company claiming to connect the world’s patients to better treatments, in turn, improving health. The firm takes advantage of the imaging and computing power of